![](/img/cover-not-exists.png)
Long-term administration of active immunotherapy CAD106 in phase IIa open-label extension studies in Alzheimer's disease patients
Ana Graf, Niels Andreasen, Martin Farlow, Marie-Emmanuelle Riviere, Peter Quarg, Angelika Caputo, Igor Vostiar, Bengt Winblad, Jean-Marc OrgogozoVolume:
8
Year:
2012
Language:
english
DOI:
10.1016/j.jalz.2012.05.493
File:
PDF, 146 KB
english, 2012